How does the use of digital tools impact the identification and management of patients with tuberculosis-associated complications?
How does the use of digital tools impact the tracking and reporting of adverse drug reactions associated with tuberculosis treatment?
What are the current challenges in the management of tuberculosis in patients with immunocompromised conditions?